Hansa Biopharma to Participate in LSX Congress USA in Boston
Hansa Biopharma AB announced that Fredrik Röök, VP Business Development, will speak at the LSX Congress USA in Boston on September 23, 2026. He will join a panel on global biopharma expansion strategies.
Hansa Biopharma AB confirmed its participation in the LSX Congress USA event, taking place in Boston on Wednesday, September 23, 2026. Fredrik Röök, the company's Vice President of Business Development, is scheduled to speak on a panel.
The panel discussion, titled “Breaking into New Markets: Strategies for Global Biopharma Expansion,” will commence at 11:00 a.m. EST. The session aims to explore strategies for companies looking to expand their reach globally within the biopharmaceutical sector.
Hansa Biopharma, headquartered in Lund, Sweden, is a biopharmaceutical company focused on developing and commercializing treatments for rare and life-threatening diseases. The company is listed on Nasdaq Stockholm under the ticker symbol HNSA.
Individuals interested in meeting with Hansa Biopharma's management during the congress are invited to contact the company directly via email at ir@hansabiopharma.com.